Session Information
-
WCLC 2022
2022 World Conference on Lung Cancer
As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2015
All times listed are in Vienna, Austria Time, CEST (UTC+2:00)
PL - Plenary
IBS - Interactive Breakfast Session (in-person attendees only)
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
P - Posters
EP - ePosters
WS - Workshops
LA – Lectureship Awards
IS - Industry Symposium
August 5 Fri
Aug 5 Saturday
August 6 Sat
Aug 6 Sunday
August 7 Sun
Aug 7 Monday
August 8 Mon
Aug 8 Tuesday
August 9 Tue
Aug 9
-
+
ES29 - Palliative Radiotherapy in Metastatic NSCLC: State of the Art in an Era of New Hope
- 10:45 - 11:45
- 8/09/2022
- Location: Hall C2
- IASLC CME Accredited
- Type: Education Session
- Track: Metastatic Non-small Cell Lung Cancer - Palliative Radiotherapy
- Moderators:Fiona Hegi-Johnson, Joachim Widder
-
+
Session Moderator
10:45 - 10:46 | Presenter: Fiona Hegi-Johnson
- Abstract
Loading... -
+
Session Moderator
10:45 - 10:46 | Presenter: Joachim Widder
- Abstract
Loading... -
+
ES29.01 - Session Introduction
10:45 - 10:46 | Presenter: Fiona Hegi-Johnson
- Abstract
Loading... -
+
ES29.02 - Session Introduction
10:46 - 10:47 | Presenter: Joachim Widder
- Abstract
Loading... -
+
ES29.03 - Radiotherapy of Brain Mets: Which Technique for Which Tumor?
10:47 - 10:59 | Presenter: Yu Yang Soon
- Abstract
Loading... -
+
ES29.04 - Management of Brain Mets: What Is the Current Role of Radiotherapy in an Era of Effective Systemic Therapies?
10:59 - 11:11 | Presenter: Margot Lehman
- Abstract
Loading... -
+
ES29.05 - The Clinical Integration of Radiotherapy and Systemic Therapy in Metastatic Disease
11:11 - 11:23 | Presenter: Shilo Lefresne
- Abstract
Loading... -
+
ES29.06 - Radiobiology of Palliative Radiotherapy: Integration with Emerging Systemic Therapies
11:23 - 11:35 | Presenter: Magnus Dillon
- Abstract
Loading... -
+
ES29.07 - Is There an Inexpensive, Effective Alternative to Nicotine Replacement Therapy (NRT)?
11:35 - 11:40 | Presenter: Magdalena Cedzynska
- Abstract
Loading... -
+
ES29.08 - Live Q&A
11:40 - 11:45
- Abstract
Loading...
-
+
ES30 - Leveraging the Power of Immunotherapy for SCLC
- 10:45 - 11:45
- 8/09/2022
- Location: Strauss 1/2
- IASLC CME Accredited
- Type: Education Session
- Track: Small Cell Lung Cancer and Neuro-Endocrine Tumors
- Moderators:Giorgio Scagliotti, Raffaele Califano
-
+
Session Moderator
10:45 - 10:46 | Presenter: Giorgio Scagliotti
- Abstract
Loading... -
+
Session Moderator
10:45 - 10:46 | Presenter: Raffaele Califano
- Abstract
Loading... -
+
ES30.01 - Session Introduction
10:45 - 10:46 | Presenter: Giorgio Scagliotti
- Abstract
Loading... -
+
ES30.02 - Session Introduction
10:46 - 10:47 | Presenter: Raffaele Califano
- Abstract
Loading... -
+
ES30.03 - Transcriptional Subtypes and Impact of Immune Checkpoint Inhibitors
10:47 - 10:59 | Presenter: Christine Hann
- Abstract
Loading... -
+
ES30.04 - State of the Art and Perspectives in Limited Stage SCLC
10:59 - 11:11 | Presenter: Sumitra Thongprasert
- Abstract
Loading... -
+
ES30.05 - Novel Strategies Other Than IO in the Front-Line Setting
11:11 - 11:23 | Presenter: Jens Benn Sørensen
- Abstract
Loading... -
+
ES30.06 - Novel Immunotherapies Beyond PD-(L1) and CTLA-4 Inhibition
11:23 - 11:35 | Presenter: Egbert Smit
- Abstract
Loading... -
+
ES30.07 - Live Q&A
11:35 - 11:45
- Abstract
Loading...
-
+
ES31 - Survivorship across the Cancer Continuum for Patients Treated with Immunotherapies and Targeted Therapies
- 10:45 - 11:45
- 8/09/2022
- Location: Lehar 1
- IASLC CME Accredited
- Type: Education Session
- Track: Nursing and Allied Health Professionals
- Moderators:Nazanin Nouriany, Morten Quist
-
+
Session Moderator
10:59 - 11:11 | Presenter: Nazanin Nouriany
- Abstract
Loading... -
+
Session Moderator
10:59 - 11:11 | Presenter: Morten Quist
- Abstract
Loading... -
+
ES31.01 - Session Introduction
10:45 - 10:46 | Presenter: Nazanin Nouriany
- Abstract
Loading... -
+
ES31.02 - Session Introduction
10:46 - 10:47 | Presenter: Morten Quist
- Abstract
Loading... -
+
ES31.03 - Long-Term Immunotherapy Survivors of Advanced Non-small Cell Lung Cancer: The Survivorship Experience
10:47 - 10:59 | Presenter: Michelle M Turner
- Abstract
Loading... -
+
ES31.04 - Survivorship and Financial Toxicity in Lung Cancer
10:59 - 11:11 | Presenter: Paula Shepherd
- Abstract
Loading... -
+
ES31.05 - Fear of Cancer Progression in Patients Treated with Novel Therapies
11:11 - 11:23 | Presenter: Fiona Lynch
- Abstract
Loading... -
+
ES31.06 - Impact of Body Composition, Nutritional and Inflammatory Status on Outcome of Non-small Cell Lung Cancer Patients Treated with Immunotherapy
11:23 - 11:35 | Presenter: Ilaria Trestini
- Abstract
Loading... -
+
ES31.07 - Live Q&A
11:35 - 11:45
- Abstract
Loading...
-
+
MA12 - Pathology: Tumour Diagnostics
- 10:45 - 11:45
- 8/09/2022
- Location: Hall C7
- Not for CME Credit
- Type: Mini Oral
- Track: Pathology
- Moderators:Aleks Ryska, Deepali Jain
-
+
Session Moderator
11:37 - 11:45 | Presenter: Aleks Ryska
- Abstract
Loading... -
+
Session Moderator
11:37 - 11:45 | Presenter: Deepali Jain
- Abstract
Loading... -
+
MA12.01 - Session Introduction
10:45 - 10:46 | Presenter: Aleks Ryska
- Abstract
Loading... -
+
MA12.02 - Session Introduction
10:46 - 10:47 | Presenter: Deepali Jain
- Abstract
Loading... -
+
MA12.03 - Mechanims of Immune Evasion in Patients With KRAS-Mutant Lung Adenocarcinoma: A Role of MAPK Pathway Activation
10:47 - 10:52 | Presenter: Dwayne Deshon Naves
- Abstract
Loading... -
+
MA12.04 - SAKK 16/14: CD8 T Cell Positioning Correlates with Survivalin Stage IIIA(N2) NSCLC After Neoadjuvant Immunotherapy
10:52 - 10:57 | Presenter: Sacha I Rothschild
- Abstract
Loading... -
+
MA12.05 - Economic Impact of Delaying Care With Single-Gene Testing Versus Next-Generation Sequencing in Non-small Cell Lung Cancer
10:57 - 11:02 | Presenter: Brandon Sheffield
- Abstract
Loading... -
+
MA12.06 - Discussant
11:02 - 11:12 | Presenter: Ming-Sound Tsao
- Abstract
Loading... -
+
MA12.07 - Defining Morphologic Features of Invasion in Pulmonarynon-Mucinousadenocarcinoma With Lepidic Growth
11:12 - 11:17 | Presenter: Erik Thunnissen
- Abstract
Loading... -
+
MA12.08 - Pagetoid Growth of Squamous Cell Carcinoma with a Subsolid Component
11:17 - 11:22 | Presenter: Federica Filipello
- Abstract
Loading... -
+
MA12.09 - Frequency and Detectability of Uncommon EGFR Mutations in NSCLC
11:22 - 11:27 | Presenter: Hazel M O'Sullivan
- Abstract
Loading... -
+
MA12.10 - Discussant
11:27 - 11:37 | Presenter: Mari Mino-Kenudson
- Abstract
Loading... -
+
MA12.11 - Live Q&A
11:37 - 11:45
- Abstract
Loading...
-
+
OA13 - Evolving Epidemiology of Lung Cancer Beyond Tobacco
- 10:45 - 11:45
- 8/09/2022
- Location: Hall C8
- Not for CME Credit
- Type: Oral
- Track: Epidemiology
- Moderators:Matthew T Warkentin, Hilary A Robbins
-
+
Session Moderator
10:47 - 10:57 | Presenter: Matthew T Warkentin
- Abstract
Loading... -
+
Session Moderator
10:47 - 10:57 | Presenter: Hilary A Robbins
- Abstract
Loading... -
+
OA13.01 - Session Introduction
10:45 - 10:46 | Presenter: Matthew T Warkentin
- Abstract
Loading... -
+
OA13.02 - Session Introduction
10:46 - 10:47 | Presenter: Hilary A Robbins
- Abstract
Loading... -
+
OA13.03 - Evaluation of Outdoor Air Pollution Exposure (PM2.5) In Female Non-smoking Lung Cancer Patients
10:47 - 10:57 | Presenter: Renelle L Myers
- Abstract
Loading... -
+
OA13.04 - Prevalence of Molecular Alterations in NSCLC and Estimated Indoor Radon in Europe: RADON EUROPE Study
10:57 - 11:07 | Presenter: Miguel Garcia Pardo
- Abstract
Loading... -
+
OA13.05 - Lung Cancer Risk Prediction Nomogram in Chinese Female Non-smokers
11:07 - 11:17 | Presenter: Lanwei Guo
- Abstract
Loading... -
+
OA13.06 - Changing Patterns of Lung Cancer Histology in an Asbestos Exposed Population
11:17 - 11:27 | Presenter: Chellan Kumarasamy
- Abstract
Loading... -
+
OA13.07 - Discussant
11:27 - 11:37 | Presenter: Chang-Chuan Chan
- Abstract
Loading... -
+
OA13.08 - Live Q&A
11:37 - 11:45
- Abstract
Loading...
-
+
ES32 - Beyond Tobacco: Environmental Risk Factors for Lung Cancer
- 12:00 - 13:00
- 8/09/2022
- Location: Hall C1
- IASLC CME Accredited
- Type: Education Session
- Track: Epidemiology
- Moderators:Christine D Berg, Paolo Boffetta
-
+
Session Moderator
12:50 - 13:00 | Presenter: Christine D Berg
- Abstract
Loading... -
+
Session Moderator
12:50 - 13:00 | Presenter: Paolo Boffetta
- Abstract
Loading... -
+
ES32.01 - Session Introduction
12:00 - 12:01 | Presenter: Christine D Berg
- Abstract
Loading... -
+
ES32.02 - Session Introduction
12:01 - 12:02 | Presenter: Paolo Boffetta
- Abstract
Loading... -
+
ES32.03 - Outdoor Particulate Air Pollution
12:02 - 12:14 | Presenter: Pawan Kumar Singh
- Abstract
Loading... -
+
ES32.04 - What Changes Are Needed to Reach WHO Particulate Matter Standards: Particular Emphasis on Power Generation and Transportation
12:14 - 12:26 | Presenter: Paolo Boffetta
- Abstract
Loading... -
+
ES32.05 - Indoor Air Pollution, Genetic Susceptibility, and Lung Cancer among Women in Asia Without a Smoking History
12:26 - 12:38 | Presenter: Chunxia Su
- Abstract
Loading... -
+
ES32.06 - Effects of Climate Change: Treatment Delays during Natural Disasters Lessen Lung Cancer Patient Survival
12:38 - 12:50 | Presenter: Roselle De Guzman
- Abstract
Loading... -
+
ES32.07 - Live Q&A
12:50 - 13:00
- Abstract
Loading...
-
+
ES33 - Management of Oligometastatic and Multi-Focal Lung Cancer
- 12:00 - 13:00
- 8/09/2022
- Location: Hall C2
- IASLC CME Accredited
- Type: Education Session
- Track: Locally Advanced Non-small Cell Lung Cancer - Oligometastatic
- Moderators:Alexander Louie
-
+
Session Moderator
12:00 - 12:00 | Presenter: Alexander Louie
- Abstract
Loading... -
+
Session Moderator
12:00 - 12:00 | Presenter: Shanda Haley Blackmon
- Abstract
Loading... -
+
ES33.01 - Session Introduction
12:00 - 12:01 | Presenter: Shanda Haley Blackmon
- Abstract
Loading... -
+
ES33.02 - Session Introduction
12:01 - 12:02 | Presenter: Alexander Louie
- Abstract
Loading... -
+
ES33.03 - Role of Ablation in Multifocal or Oligometastatic Lung Carcinoma
12:02 - 12:14 | Presenter: Carole Ridge
- Abstract
Loading... -
+
ES33.04 - Surgery for Oligometastatic and Multi-Focal Lung Cancer
12:14 - 12:26 | Presenter: Loretta Erhunmwunsee
- Abstract
Loading... -
+
ES33.05 - Radiation for Oligometastatic Lung Cancer
12:26 - 12:38 | Presenter: Fiona Hegi-Johnson
- Abstract
Loading... -
+
ES33.06 - Multimodality Management of Multi-Focal Lung Cancer
12:38 - 12:50 | Presenter: Walter Weder
- Abstract
Loading... -
+
ES33.07 - Live Q&A
12:50 - 13:00
- Abstract
Loading...
-
+
ES34 - Updates in Radiology, Pulmonology, and Staging
- 12:00 - 13:00
- 8/09/2022
- Location: Strauss 1/2
- IASLC CME Accredited
- Type: Education Session
- Track: Pulmonology, Radiology, and Staging
- Moderators:Lynette Teo, David Carbone
-
+
Session Moderator
12:00 - 12:00 | Presenter: Lynette Teo
- Abstract
Loading... -
+
Session Moderator
12:00 - 12:00 | Presenter: David Carbone
- Abstract
Loading... -
+
Session Moderator
12:50 - 13:00 | Presenter: ANKUSH JAJODIA
- Abstract
Loading... -
+
ES34.01 - Session Introduction
12:00 - 12:01 | Presenter: Lynette Teo
- Abstract
Loading... -
+
ES34.02 - Session Introduction
12:01 - 12:02 | Presenter: ANKUSH JAJODIA
- Abstract
Loading... -
+
ES34.02 - Session Introduction
12:01 - 12:02 | Presenter: David Carbone
- Abstract
Loading... -
+
ES34.03 - Advances in Lung Cancer Imaging
12:02 - 12:14 | Presenter: Jin Mo Goo
- Abstract
Loading... -
+
ES34.04 - Diagnostic and Interventional Bronchoscopy: Updates and Future
12:14 - 12:26 | Presenter: Daniela Gompelmann
- Abstract
Loading... -
+
ES34.05 - TNM Staging: Essential and Other Emerging Concepts
12:26 - 12:38 | Presenter: Ramon Rami-Porta
- Abstract
Loading... -
+
ES34.05 - TNM Staging: Essential and Other Emerging Concepts
12:26 - 12:38 | Presenter: David Carbone
- Abstract
Loading... -
+
ES34.06 - Inclusion of Molecular/Genetic Factors in the TNM Staging System, Is It Possible?
12:38 - 12:50 | Presenter: David Carbone
- Abstract
Loading... -
+
ES34.07 - Live Q&A
12:50 - 13:00
- Abstract
Loading...
-
+
ES35 - High-Plex Spatial Technologies for Molecular Tumor Analysis and Single-Cell Studies in Thoracic Oncology Research and Future Clinical Uses
- 12:00 - 13:00
- 8/09/2022
- Location: Lehar 1
- IASLC CME Accredited
- Type: Education Session
- Track: Tumor Biology and Biomarkers
- Moderators:Martin Filipits, Caroline Dive
-
+
Session Moderator
12:00 - 12:00 | Presenter: Martin Filipits
- Abstract
Loading... -
+
Session Moderator
12:00 - 12:00 | Presenter: Caroline Dive
- Abstract
Loading... -
+
ES35.01 - Session Introduction
12:00 - 12:01 | Presenter: Martin Filipits
- Abstract
Loading... -
+
ES35.02 - Session Introduction
12:01 - 12:02 | Presenter: Caroline Dive
- Abstract
Loading... -
+
ES35.03 - Discovery of Predictive Biomarkers for Immunotherapy Using Deep Spatial Tissue Analysis in Lung Cancer
12:02 - 12:14 | Presenter: David Rimm
- Abstract
Loading... -
+
ES35.04 - Single-Cell Transciptomics to Study Immunotherapy Responses in Resectable Non-small Cell Lung Cancer
12:14 - 12:26 | Presenter: Kellie Smith
- Abstract
Loading... -
+
ES35.05 - Computational Approaches to Analyze and Interpret High-Plex Spatial and Single-Cell Molecular Tumor Studies
12:26 - 12:38 | Presenter: Melissa Davis
- Abstract
Loading... -
+
ES35.06 - A Multi-Omics Approach for Delineating Tissue Signatures of Immunotherapy Response in Lung Cancer
12:38 - 12:50 | Presenter: Arutha Kulasinghe
- Abstract
Loading... -
+
ES35.07 - Live Q&A
12:50 - 13:00
- Abstract
Loading...
-
+
MA13 - Update on ROS1 Inhibitors and New Pathways
- 12:00 - 13:00
- 8/09/2022
- Location: Hall C7
- Not for CME Credit
- Type: Mini Oral
- Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- Moderators:Lorenza Landi, Jii Bum (Joy) Lee
-
+
Session Moderator
12:52 - 13:00 | Presenter: Lorenza Landi
- Abstract
Loading... -
+
Session Moderator
12:52 - 13:00 | Presenter: Jii Bum (Joy) Lee
- Abstract
Loading... -
+
MA13.01 - Session Introduction
12:00 - 12:01 | Presenter: Lorenza Landi
- Abstract
Loading... -
+
MA13.02 - Session Introduction
12:01 - 12:02 | Presenter: Jii Bum (Joy) Lee
- Abstract
Loading... -
+
MA13.03 - Integrated Efficacy and Safety of Brigatinib Following Alectinib Treatment in the ALTA-2 and J-ALTA Studies
12:02 - 12:07 | Presenter: Sai-Hong Ignatius Ou
- Abstract
Loading... -
+
MA13.04 - Entrectinib in Patients with ROS1 Fusion-Positive (ROS1-fp) NSCLC: Updated Efficacy and Safety Analysis
12:07 - 12:12 | Presenter: Yun Fan
- Abstract
Loading... -
+
MA13.05 - TA0953/HM06, a Novel RET-specific Inhibitor Effective in Extracranial and CNS Disease Models of NSCLC with RETfusions
12:12 - 12:17 | Presenter: Igor Odintsov
- Abstract
Loading... -
+
MA13.06 - Discussant
12:17 - 12:27 | Presenter: Lorenza Landi
- Abstract
Loading... -
+
MA13.07 - TROPION-Lung02: Initial Results for Datopotamab Deruxtecan Plus Pembrolizumab and Platinum Chemotherapy in Advanced NSCLC
12:27 - 12:32 | Presenter: Benjamin Levy
- Abstract
Loading... -
+
MA13.08 - A Phase 1 Trial of Sapanisertib and Telaglenastat (CB-839) in Patients With Advanced NSCLC (NCI 10327): Results from Dose Escalation
12:32 - 12:37 | Presenter: Jonathan Riess
- Abstract
Loading... -
+
MA13.09 - Time from Immune Checkpoint Inhibitor to Sotorasib Use Correlates with Risk of Hepatotoxicity in Non-small Cell Lung Cancer
12:37 - 12:42 | Presenter: Sagar Rakshit
- Abstract
Loading... -
+
MA13.10 - Discussant
12:42 - 12:52 | Presenter: Paolo Bironzo
- Abstract
Loading... -
+
MA13.11 - Live Q&A
12:52 - 13:00
- Abstract
Loading...
first
prev
